Results from Phase 2 Studies of Oral Ozanimod in Crohns Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017

In the STEPSTONE openlabel study ozanimod demonstrated meaningful clinical and endoscopic improvements in patients with moderately to severely active Crohns disease at week 12 In the TOUCHSTONE openlabel extension study ozani...